News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Stocktwits Earnings
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Cipher Mining (NASDAQ:CIFR) shares dropped 6.4% after reporting a wider-than-expected quarterly loss and lower-than-consensus revenue. Despite broad analyst optimism with a "Moderate Buy" rating and an average price target of $28.61, analysts have revised down several near-term earnings forecasts for 2026, indicating deeper losses. …
(All figures are presented in U.S. Dollars) Epuris® sales were $4.1 million during the quarter, a year-over-year increase of 14% compared to Q2 2025 and a sequential increase of 4% over Q1 2026 Letter of Intent executed with the pan-Canadian Pharmaceutical Alliance, securing expanded …
(All figures are presented in U.S. Dollars) Epuris® sales were $4.1 million during the quarter, a year-over-year increase of 14% compared to Q2 2025 and a sequential increase of 4% over Q1 2026 Letter of Intent executed with the pan-Canadian Pharmaceutical Alliance, securing expanded …
Riot Platforms experienced an 18.3% pre-market surge due to a significant $9.1 billion, 20-year AI data center contract with Anthropic, setting it apart from its crypto mining peers like CleanSpark, Cipher Mining, Hut 8, and TeraWulf, which saw only modest gains. This deal is …
Citizens has reiterated its "Market Outperform" rating and $30.00 price target for Cipher Mining (NASDAQ: CIFR), citing the company's progress in its AI infrastructure platform. The firm adjusted its estimates due to a slightly lower Bitcoin price outlook and higher near-term operating expenses, but …
(RTTNews) - Shares of Innate Pharma S.A. (IPHA), a clinical-stage company, surge over 25% after the company announced a strategic partnership with Swedish Orphan Biovitrum AB (SOBI.ST) to enable initiation of the TELLOMAK-3 confirmatory Phase 3 study of Lacutamab, an investigational anti-KIR3DL2 antibody in …
(RTTNews) - Swedish Orphan Biovitrum AB (SOBI.ST) and Innate Pharma (IPHA, IPH, IPH.PA) have entered a strategic partnership to enable initiation of the TELLOMAK-3 confirmatory Phase 3 study in cutaneous T cell lymphoma, a key step toward filing for accelerated approval of lacutamab in …
STOCKHOLM, Aug. 10, 2026 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) and Innate Pharma SA (Euronext Paris: IPH) (NASDAQ: IPHA) ("Innate" or the "Company") today announced that they have entered a strategic partnership to enable initiation of the TELLOMAK-3 confirmatory Phase 3 study …
J.P. Morgan has maintained a Buy rating for Cipher Mining (CIFR) with a price target of $22.00, following the company's reported GAAP net loss of $267.53 million for the quarter ending June 30. Despite this, another analyst from Morgan Stanley also assigned a Buy …
The California State Teachers Retirement System significantly increased its stake in Cipher Mining Inc. by 22.2% in the first quarter, acquiring 66,518 shares and bringing its total holdings to 365,966 shares valued at approximately $4.71 million. This increase occurred despite Cipher Mining reporting a …
This article provides news and analysis for Cipher Mining Inc (CIFR) stock, highlighting its current market performance and recent developments. It notes that Cipher Mining Inc's stock is down 3.87% and also reports on a significant event where crypto mining stocks, including CIFR, surged …
Search by ticker symbol or company name and select a result to open its chart.